Search

Your search keyword '"Marktel S"' showing total 264 results
Start Over Author "Marktel S" Language english
264 results on '"Marktel S"'

3. Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation

Author

Crucitti, L, Crocchiolo, R, Toffalori, C, Mazzi, B, Greco, R, Signori, A, Sizzano, F, Chiesa, L, Zino, E, Lupo Stanghellini, M T, Assanelli, A, Carrabba, M G, Marktel, S, Marcatti, M, Bordignon, C, Corti, C, Bernardi, M, Peccatori, J, Bonini, C, Fleischhauer, K, Ciceri, F, and Vago, L

Published
2015
Full Text
View/download PDF

4. Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors

Author

Peccatori, J, Forcina, A, Clerici, D, Crocchiolo, R, Vago, L, Stanghellini, M T L, Noviello, M, Messina, C, Crotta, A, Assanelli, A, Marktel, S, Olek, S, Mastaglio, S, Giglio, F, Crucitti, L, Lorusso, A, Guggiari, E, Lunghi, F, Carrabba, M, Tassara, M, Battaglia, M, Ferraro, A, Carbone, M R, Oliveira, G, Roncarolo, M G, Rossini, S, Bernardi, M, Corti, C, Marcatti, M, Patriarca, F, Zecca, M, Locatelli, F, Bordignon, C, Fleischhauer, K, Bondanza, A, Bonini, C, and Ciceri, F

Published
2015
Full Text
View/download PDF

15. T CELL DEPLETED HAPLOIDENTICAL STEM CELL TRANSPLANTATION FOLLOWED BY ADD-BACKS OF SUICIDE-GENE MODIFIED DONOR T-CELLS OFFERS LONG TERM SURVIVAL FREE OF IMMUNE SUPPRESSION TREATMENT: A 7 YEARS FOLLOW-UP IN 56 PATIENTS: PH-O084

Author

Lupo-Stanghellini, M. T., Greco, R., Oliveira, G., Peccatori, J., Marcatti, M., Guggiari, E., Lunghi, F., Marktel, S., Giglio, F., Bondanza, A., Malerba, A., Trinca, S., Corti, C., Bernardi, M., Lambiase, A., Bordignon, C., Bonini, C., and Ciceri, F.

Published
2014

18. Case Report: Invasive Fungal Infection and Daratumumab: A Case Series and Review of Literature.

Author

Farina, Francesca, Ferla, V., Marktel, S., Clerici, D., Mastaglio, S., Perini, T., Oltolini, C., Greco, R., Aletti, F., Assanelli, A., Lupo-Stanghellini, M. T., Bernardi, M., Corti, C., Ciceri, F., and Marcatti, M.

Subjects
MYCOSES, DARATUMUMAB, LITERATURE reviews, MULTIPLE myeloma, MONOCLONAL antibodies
Abstract

Life expectancy of multiple myeloma (MM) patients has improved in last years due to the advent of anti-CD38 monoclonal antibodies in combination with immunomodulators and proteasome inhibitors. However, morbidity and mortality related to infections remain high and represent a major concern. This paper describes the "real life" risk of invasive fungal infections (IFI) in patients treated with daratumumab-based therapy and reviews the relevant literature. In a series of 75 patients we only observed three cases of fungal pneumonia. Unfortunately, the early signs and symptoms were not specific for fungal infection. Diagnostic imaging, microbiology and patient history, especially previous therapies, are critical in the decision to start antifungal treatment. Recognising the subgroup of MM patients with high risk of IFI can increase the rate of diagnosis, adequate treatment and MM-treatment recovery. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

23. Genotypes and haplotypes in the 3′ untranslated region of the HLA-G gene and their association with clinical outcome of hematopoietic stem cell transplantation for beta-thalassemia

Author

Sizzano, F., Testi, M., Zito, L., Crocchiolo, R., Troiano, M., Mazzi, B., Turchiano, G., Torchio, M., Pultrone, C., Gregori, S., Chiesa, R., Gaziev, J., Sodani, P., Marktel, S., Amoroso, A., Roncarolo, M. G., Lucarelli, G., Ciceri, F., Andreani, M., and Fleischhauer, K.

Published
2012
Full Text
View/download PDF

28. Risk of complications of haematopoietic stem cell collection in paediatric sibling donors: an EBMT Paediatric Diseases Working Party prospective observational study: O404

Author

Styczynski, J., Balduzzi, A., Gil, L., Ehlert, K., Fagioli, F., Hamladji, R.-M., Marktel, S., Yesilipek, A., Matulova, M., Dalle, J.-H., Wachowiak, J., Miano, M., Varotto, S., Diaz, M. A., Vermylen, C., Eyrich, M., Badell, I., Dreger, P., Gozdzik, J., Hutt, D., Rascon, J., Labopin, M., Elarouci, N., Dini, G., and Peters, C.

Published
2011

29. Sickle cell disease: An international survey of results of HLA-identical sibling hematopoietic stem cell transplantation

Author

Gluckman, E., Cappelli, B., Bernaudin, F., Labopin, M., Volt, F., Carreras, J., Simoes, B. P., Ferster, A., Dupont, S., De La Fuente, J., Dalle, J. -H., Zecca, M., Walters, M. C., Krishnamurti, L., Bhatia, M., Leung, K., Yanik, G., Kurtzberg, J., Dhedin, N., Kuentz, M., Michel, G., Apperley, J., Lutz, P., Neven, B., Bertrand, Y., Vannier, J. P., Ayas, M., Cavazzana, M., Matthes-Martin, S., Rocha, V., Elayoubi, H., Kenzey, C., Bader, P., Locatelli, Franco, Ruggeri, A., Eapen, M., Bordon, V., Labarque, V., Pereira, M., Bittencourt, H., Petersen, H., Deconninck, E., Jubert, C., Perrin, J., Cahn, J. Y., Bruno, B., Bordigoni, P., Mechinaud, F., Vernant, J. P., Stephan, J. L., Suttorp, M., Strahm, B., Da Cunha, C. B., Garwer, B., Rothmayer, M., Wendelin, K., Graphakos, S., Tbakhi, A., Naeimi, N., Zuckerman, T., Sharon, P. B., Yaniv, I., Amos, T., Prete, A., Lo Nigro, L., Lanino, E., Faraci, M., Ciceri, F., Marktel, S., De Simone, G., Messina, C., Bartolomeo, P. D. I., Santarone, S., Vallisa, D., Bertaina, A., Arcese, W., Foa, R., Berger, M., Maximova, N., Wallet, S., Bazuaye, G. N., Maschan, A., De Heredia, C. D., Bieler, C. B., Pato, J. R., Heras, I., Trevor, R., Abayomi, K., Thomson, J., Fasth, A., Frodin, U., Ljugman, P., Ansari, M., Gungor, T., Unal, E., Pehlivan, M., Anak, S., Ozturk, G., Unal, A., Lawson, S., Keshani, J., Drake, A., Wynn, R., Williams, J., Jagsia, M., Leung, W., Abraham, A., Sahdey, I., Margolis, D., Eames, G., Horwitz, E., Cowan, M., Kapoor, N., Rowley, S., Megason, G., Rogers, Z., Bolanos-Meade, J., Hudspeth, M., Rosenthal, J., Olson, T., Kassow, K., Selby, G., Haines, H., Chaudhury, S., Gluckman, E., Cappelli, B., Bernaudin, F., Labopin, M., Volt, F., Carreras, J., Simoes, B. P., Ferster, A., Dupont, S., De La Fuente, J., Dalle, J. -H., Zecca, M., Walters, M. C., Krishnamurti, L., Bhatia, M., Leung, K., Yanik, G., Kurtzberg, J., Dhedin, N., Kuentz, M., Michel, G., Apperley, J., Lutz, P., Neven, B., Bertrand, Y., Vannier, J. P., Ayas, M., Cavazzana, M., Matthes-Martin, S., Rocha, V., Elayoubi, H., Kenzey, C., Bader, P., Locatelli, F., Ruggeri, A., Eapen, M., Bordon, V., Labarque, V., Pereira, M., Bittencourt, H., Petersen, H., Deconninck, E., Jubert, C., Perrin, J., Cahn, J. Y., Bruno, B., Bordigoni, P., Mechinaud, F., Vernant, J. P., Stephan, J. L., Suttorp, M., Strahm, B., Da Cunha, C. B., Garwer, B., Rothmayer, M., Wendelin, K., Graphakos, S., Tbakhi, A., Naeimi, N., Zuckerman, T., Sharon, P. B., Yaniv, I., Amos, T., Prete, A., Lo Nigro, L., Lanino, E., Faraci, M., Ciceri, F., Marktel, S., De Simone, G., Messina, C., Bartolomeo, P. D. I., Santarone, S., Vallisa, D., Bertaina, A., Arcese, W., Foa, R., Berger, M., Maximova, N., Wallet, S., Bazuaye, G. N., Maschan, A., De Heredia, C. D., Bieler, C. B., Pato, J. R., Heras, I., Trevor, R., Abayomi, K., Thomson, J., Fasth, A., Frodin, U., Ljugman, P., Ansari, M., Gungor, T., Unal, E., Pehlivan, M., Anak, S., Ozturk, G., Unal, A., Lawson, S., Keshani, J., Drake, A., Wynn, R., Williams, J., Jagsia, M., Leung, W., Abraham, A., Sahdey, I., Margolis, D., Eames, G., Horwitz, E., Cowan, M., Kapoor, N., Rowley, S., Megason, G., Rogers, Z., Bolanos-Meade, J., Hudspeth, M., Rosenthal, J., Olson, T., Kassow, K., Selby, G., Haines, H., Chaudhury, S., France Monacord, Centre Scientifique de Monaco (CSM), CHI Créteil, Centre de Recherche Saint-Antoine (CR Saint-Antoine), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Pierre et Marie Curie - Paris 6 (UPMC), Eurocord, Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Institut Universitaire d'Hématologie (IUH), Université Paris Diderot - Paris 7 (UPD7)-Université Paris Diderot - Paris 7 (UPD7), Hôpital Universitaire des Enfants - Reine Fabiola, Université Libre de Bruxelles, Equipe NEMESIS - Centre de Recherches de l'Institut du Cerveau et de la Moelle épinière (NEMESIS-CRICM), Centre de Recherche de l'Institut du Cerveau et de la Moelle épinière (CRICM), Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Pierre et Marie Curie - Paris 6 (UPMC)-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Pierre et Marie Curie - Paris 6 (UPMC), Unité d'Hémato-Immunologie pédiatrique [Hôpital Robert Debré, Paris], Service d'Immuno-hématologie pédiatrique [Hôpital Robert Debré, Paris], Hôpital Robert Debré-Hôpital Robert Debré, Duke University Medical Center, Service de Greffe de Moelle - Unité AJA, Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (APHP), Service d'hématologie clinique, Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Hôpital de la Timone [CHU - APHM] (TIMONE), Department of Haematology, Hôpital Civil, Hopital Civil, Département d'Immunologie, hématologie et rhumatologie pédiatriques [Hôpital Necker-Enfants malades - APHP], CHU Necker - Enfants Malades [AP-HP], Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL), Hemostase, Endothelium, Angiogenese (UMR_S_553), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Diderot - Paris 7 (UPD7), Physiopathologie, Autoimmunité, maladies Neuromusculaires et THErapies Régénératrices (PANTHER), Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Imagine - Institut des maladies génétiques (IMAGINE - U1163), Centre National de la Recherche Scientifique (CNRS)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Churchill Hospital [Breast Care Unit], Churchill Hospital Oxford Centre for Haematology, Santa Lucia Foundation, IRCSS, Rome, Medical College of Wisconsin, National Institute for Health Research, Centre de Recherche Saint-Antoine (UMRS893), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut Universitaire d'Hématologie (IUH), Hôpital Universitaire des Enfants Reine Fabiola [Bruxelles, Belgique] (HUDERF), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), UCL - SSS/IREC/PEDI - Pôle de Pédiatrie, and UCL - (SLuc) Service d'hématologie et d'oncologie pédiatrique

Subjects
Male, HYDROXYUREA, Transplantation Conditioning, [SDV]Life Sciences [q-bio], medicine.medical_treatment, CHILDREN, Hematopoietic stem cell transplantation, Biochemistry, THALASSEMIA, 0302 clinical medicine, HLA Antigens, Surveys and Questionnaires, 1114 Paediatrics And Reproductive Medicine, Child, ComputingMilieux_MISCELLANEOUS, CÉLULAS-TRONCO, Hazard ratio, Graft Survival, BONE-MARROW TRANSPLANT, Hematopoietic Stem Cell Transplantation, Hematology, Sickle cell anemia, 3. Good health, Survival Rate, medicine.anatomical_structure, Treatment Outcome, Settore MED/38 - PEDIATRIA GENERALE E SPECIALISTICA, 030220 oncology & carcinogenesis, Child, Preschool, Histocompatibility, [SDV.IMM]Life Sciences [q-bio]/Immunology, Female, Life Sciences & Biomedicine, medicine.medical_specialty, Adolescent, Anemia, Immunology, Anemia, Sickle Cell, 1102 Cardiovascular Medicine And Haematology, Disease-Free Survival, 03 medical and health sciences, Internal medicine, MANAGEMENT, medicine, Humans, ANEMIA, Survival rate, Transplantation, Science & Technology, business.industry, Siblings, Sickle cell disease, Infant, 1103 Clinical Sciences, ADULTS, Cell Biology, medicine.disease, LIFE, EXPERT PANEL, Bone marrow, FOLLOW-UP, business, 030215 immunology
Abstract

Despite advances in supportive therapy to prevent complications of sickle cell disease (SCD), access to care is not universal. Hematopoietic cell transplantation is, to date, the only curative therapy for SCD, but its application is limited by availability of a suitable HLA-matched donor and lack of awareness of the benefits of transplant. Included in this study are 1000 recipients of HLA-identical sibling transplants performed between 1986 and 2013 and reported to the European Society for Blood and Marrow Transplantation, Eurocord, and the Center for International Blood and Marrow Transplant Research. The primary endpoint was event-free survival, defined as being alive without graft failure; risk factors were studied using a Cox regression models. The median age at transplantation was 9 years, and the median follow-up was longer than 5 years. Most patients received a myeloablative conditioning regimen (n = 873; 87%); the remainder received reduced-intensity conditioning regimens (n = 125; 13%). Bone marrow was the predominant stem cell source (n = 839; 84%); peripheral blood and cord blood progenitors were used in 73 (7%) and 88 (9%) patients, respectively. The 5-year event-free survival and overall survival were 91.4% (95% confidence interval, 89.6%-93.3%) and 92.9% (95% confidence interval, 91.1%-94.6%), respectively. Event-free survival was lower with increasing age at transplantation (hazard ratio [HR], 1.09; P < .001) and higher for transplantations performed after 2006 (HR, 0.95; P = .013). Twenty-three patients experienced graft failure, and 70 patients (7%) died, with the most common cause of death being infection. The excellent outcome of a cohort transplanted over the course of 3 decades confirms the role of HLA-identical sibling transplantation for children and adults with SCD.

Published
2017

30. Safety of retroviral gene marking with a truncated NGF receptor

Author

Bonini, C., Grez, M., Traversari, C., Ciceri, F., Marktel, S., Ferrari, G., Dinauer, M., Sadat, M., Aiuti, A., Deola, S., Radrizzani, M., Hagenbeek, A., Apperley, J., Ebeling, S., Martens, A., Kolb, H.J., Weber, M., Lotti, F., Grande, A., Weissinger, E., Bueren, J.A., Lamana, M., Falkenburg, J.H.F., Heemskerk, M.H.M., Austin, T., Kornblau, S., Marini, F., Benati, C., Magnani, Z., Cazzaniga, S., Toma, S., Gallo-Stampino, C., Introna, M., Slavin, S., Greenberg, P.D., Bregni, M., Mavilio, F., and Bordignon, C.

Abstract

Author(s): C. Bonini (corresponding author) [1]; M. Grez [2]; C. Traversari [3]; F. Ciceri [1]; S. Marktel [1, 4]; G. Ferrari [5]; M. Dinauer [6]; M. Sadat [6]; A. Aiuti [...]

Published
2003
Full Text
View/download PDF

32. Longitudinal microbiome profile associates with the risk of major transplant-related complications in allogeneic HSCT recipients

Author

Greco R, Mancini N, Pasciuta R, Barbanti MC, Morelli M, Vago L, Giglio F, Stanghellini MTL, Forcina A, Infurnari L, Marktel S, Assanelli A, Carrabba M, Bernardi M, Corti C, Peccatori J, Clementi M, Ciceri F, Greco, R, Mancini, N, Pasciuta, R, Barbanti, Mc, Morelli, M, Vago, L, Giglio, F, Stanghellini, Mtl, Forcina, A, Infurnari, L, Marktel, S, Assanelli, A, Carrabba, M, Bernardi, M, Corti, C, Peccatori, J, Clementi, M, and Ciceri, F

Published
2016

33. Treosulfan based reduced toxicity conditioning followed by allogeneic stem cell transplantation in patients with myelofibrosis

Author

Claudiani S., Marktel S., Piemontese S., Assanelli A., Lupo-Stanghellini M. T., Carrabba M., Guggiari E., Giglio F., De Freitas T., Marcatti M., Bernardi M., Corti C., Peccatori J., Lunghi F., Ciceri F., Claudiani, S., Marktel, S., Piemontese, S., Assanelli, A., Lupo-Stanghellini, M. T., Carrabba, M., Guggiari, E., Giglio, F., De Freitas, T., Marcatti, M., Bernardi, M., Corti, C., Peccatori, J., Lunghi, F., and Ciceri, F.

Subjects
Male, Transplantation Conditioning, bone marrow transplantation, Middle Aged, Allografts, Disease-Free Survival, Survival Rate, Primary Myelofibrosis, hematopoietic stem cell transplantation, reduced-toxicity conditioning, Humans, Female, myeloproliferative disease, Unrelated Donors, treosulfan, Busulfan, Vidarabine, Aged, Stem Cell Transplantation
Abstract

Allogeneic transplantation is the only potentially curative strategy for myelofibrosis, even in the era of new drugs that so far only mitigate symptoms. The choice to proceed to allogeneic transplantation is based on several variables including age, disease phase, degree of splenomegaly, donor availability, comorbidities and iron overload. These factors, along with conditioning regimen and time to transplantation, may influence the outcome of ASCT. We report 14 patients affected by myelofibrosis with a median age of 57 years (range, 41–76) receiving a treosulfan-fludarabine based reduced toxicity conditioning. Patients (pts) received a stem cell transplantation from an HLA identical (n = 10) or matched unrelated donor (n = 4). All pts had a complete myeloablation followed by engraftment and in 12 out of 13 evaluated pts donor chimerism was 100% at 1 month. In most cases a reduction of splenomegaly and a reduction (or resolution) of bone marrow fibrosis was observed. After a median follow-up of 39 months (range, 3–106), the 3-year probability of overall survival and disease free survival was 54 +/− 14% and 46 +/− 14%, respectively. The cumulative incidence of non-relapse mortality at 2 years was 39 +/− 15%. Causes of non-relapse mortality were: infection (n = 2), GvHD (n = 2) and haemorrhage (n = 1). We can conclude that a treosulfan and fludarabine based conditioning has a potent myeloablative and anti-disease activity although non-relapse mortality remains high in this challenging clinical setting. Copyright © 2014 John Wiley & Sons, Ltd.

Published
2016

34. Nanosphere's Verigene (R) System to detect Multidrug-Resistant Gram-negative Bacterial Outbreak: a prospective study in 60 patients

Author

Barbanti MC, Mancini N, Infurnari L, Pasciuta R, Forcina A, Vago L, Giglio F, Messina C, Morelli M, Perini T, Girlanda S, Carrabba M, Stanghellini MTL, Marktel S, Assanelli A, Bernardi M, Corti C, Peccatori J, Clementi M, Ciceri F, Greco R, Barbanti, Mc, Mancini, N, Infurnari, L, Pasciuta, R, Forcina, A, Vago, L, Giglio, F, Messina, C, Morelli, M, Perini, T, Girlanda, S, Carrabba, M, Stanghellini, Mtl, Marktel, S, Assanelli, A, Bernardi, M, Corti, C, Peccatori, J, Clementi, M, Ciceri, F, and Greco, R

Published
2016

35. T-Cell Replete Haploidentical PBSC Transplantation Using Intensified Myeloablative Conditioning, Post-Transplant Cyclophosphamide and Sirolimus

Author

Greco R, Piemontese S, Cieri N, Giglio F, Morelli M, Messina C, Marcatti M, Marktel S, Carrabba M, Bernardi M, Corti C, Assanelli A, Stanghellini MTL, Bonini C, Vago L, Ciceri F, Peccatori J, Greco, R, Piemontese, S, Cieri, N, Giglio, F, Morelli, M, Messina, C, Marcatti, M, Marktel, S, Carrabba, M, Bernardi, M, Corti, C, Assanelli, A, Stanghellini, Mtl, Bonini, C, Vago, L, Ciceri, F, and Peccatori, J

Published
2016

36. Secondary solid tumors after allogeneic stem cell transplantation: active surveillance in long term follow-up

Author

Lupo-Stanghellini MT, Assanelli A, Greco R, Giglio F, Mastaglio S, Morelli M, Pavesi F, Sala E, Brambilla M, Piemontese S, Vago L, Messina C, Dalto SC, Francesca L, Perini T, Girlanda S, Malerba A, Marcatti M, Guggiari E, Marktel S, Carrabba M, Lunghi F, Bernardi M, Bonini C, Corti C, Peccatori J, Ciceri F, Lupo-Stanghellini, Mt, Assanelli, A, Greco, R, Giglio, F, Mastaglio, S, Morelli, M, Pavesi, F, Sala, E, Brambilla, M, Piemontese, S, Vago, L, Messina, C, Dalto, Sc, Francesca, L, Perini, T, Girlanda, S, Malerba, A, Marcatti, M, Guggiari, E, Marktel, S, Carrabba, M, Lunghi, F, Bernardi, M, Bonini, C, Corti, C, Peccatori, J, and Ciceri, F

Published
2016

37. HHV6 Specific T-cells are Predictor of Clinically Relevant HHV6 Infection after Allogeneic HSCT

Author

Greco R, Noviello M, Crucitti L, Racca S, Valtolina V, Pozzato M, Morelli M, Giglio F, Mannina D, Barbanti MC, Forcina A, Rolla S, Assanelli A, Carrabba M, Marktel S, Bernardi M, Corti C, Stanghellini MTL, Vago L, Peccatori J, Clementi M, Bonini C, Ciceri F, Greco, R, Noviello, M, Crucitti, L, Racca, S, Valtolina, V, Pozzato, M, Morelli, M, Giglio, F, Mannina, D, Barbanti, Mc, Forcina, A, Rolla, S, Assanelli, A, Carrabba, M, Marktel, S, Bernardi, M, Corti, C, Stanghellini, Mtl, Vago, L, Peccatori, J, Clementi, M, Bonini, C, and Ciceri, F

Published
2016

38. BIOMARKERS PREDICTING ACUTE GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS: A PROSPECTIVE STUDY IN 120 PATIENTS

Author

Vaccari LC, Barbanti MC, Giglio F, Morelli M, Mannina D, Perini T, Lazzari L, Mastaglio S, Piemontese S, Lorentino F, Forcina A, Assanelli A, Marktel S, Carrabba M, Vago L, Corti C, Bernardi M, Stanghellini MTL, Peccatori J, Ciceri F, Greco R, Vaccari, Lc, Barbanti, Mc, Giglio, F, Morelli, M, Mannina, D, Perini, T, Lazzari, L, Mastaglio, S, Piemontese, S, Lorentino, F, Forcina, A, Assanelli, A, Marktel, S, Carrabba, M, Vago, L, Corti, C, Bernardi, M, Stanghellini, Mtl, Peccatori, J, Ciceri, F, and Greco, R

Published
2016

39. Allogeneic haematopoietic stem cell transplantation in patients older than 65 years with high risk acute myeloid leukemia: results in 46 consecutive patients

Author

Sala E, Carrabba MG, Messina C, Pavesi F, Xue E, Gentner B, Vago L, Morelli M, Assanelli A, Marktel S, Lupo-Stanghellini MT, Corti C, Peccatori J, Ciceri F, Bernardi M, Sala, E, Carrabba, Mg, Messina, C, Pavesi, F, Xue, E, Gentner, B, Vago, L, Morelli, M, Assanelli, A, Marktel, S, Lupo-Stanghellini, Mt, Corti, C, Peccatori, J, Ciceri, F, and Bernardi, M

Published
2015

40. T-cell immune reconstitution predicts the outcome of Human Herpes Virus 6 Infection in 54 Patients after Allogeneic Hematopoietic Stem Cell Transplantation

Author

Greco R, Crucitti L, Noviello M, Racca S, Barbanti MC, Valtolina V, Dvir R, Vago L, Stanghellini MTL, Giglio F, Morelli M, Rolla S, Lorentino F, Orsini A, Forcina A, Assanelli A, Carrabba M, Marktel S, Bernardi M, Corti C, Peccatori J, Bonini C, Clementi M, Ciceri F, Greco, R, Crucitti, L, Noviello, M, Racca, S, Barbanti, Mc, Valtolina, V, Dvir, R, Vago, L, Stanghellini, Mtl, Giglio, F, Morelli, M, Rolla, S, Lorentino, F, Orsini, A, Forcina, A, Assanelli, A, Carrabba, M, Marktel, S, Bernardi, M, Corti, C, Peccatori, J, Bonini, C, Clementi, M, and Ciceri, F

Published
2015

41. Targeting WT1 reactivation in patients in complete remission after allogeneic haematopoietic stem cell transplantation for AML and MDS: results in 111 patients

Author

Sala E, Carrabba MG, Messina C, Vago L, Tresoldi C, Pavesi F, Xue E, Gentner B, Assanelli A, Marktel S, Lupo-Stanghellini MT, Corti C, Peccatori J, Ciceri F, Bernardi M, Sala, E, Carrabba, Mg, Messina, C, Vago, L, Tresoldi, C, Pavesi, F, Xue, E, Gentner, B, Assanelli, A, Marktel, S, Lupo-Stanghellini, Mt, Corti, C, Peccatori, J, Ciceri, F, and Bernardi, M

Published
2015

43. Antifungal Prophylaxis with Posaconazole in Allogeneic Hematopoietic Stem Cell Transplantation Using Sirolimus for Prevention of Graft-Versus-Host Disease

Author

Greco R, Barbanti MC, Forcina A, Stanghellini MTL, Giglio F, Morelli M, Vago L, Piemontese S, Messina C, Sala E, Pavesi F, Marktel S, Carrabba MG, Assanelli A, Bernardi M, Peccatori J, Corti C, Ciceri F, Greco, R, Barbanti, Mc, Forcina, A, Stanghellini, Mtl, Giglio, F, Morelli, M, Vago, L, Piemontese, S, Messina, C, Sala, E, Pavesi, F, Marktel, S, Carrabba, Mg, Assanelli, A, Bernardi, M, Peccatori, J, Corti, C, and Ciceri, F

Published
2015

44. Improving the Diagnostic Algorithm for Sepsis: Adjuvant Role of SeptiFast in 491 Consecutive Hematological Patients

Author

Barbanti MC, Greco R, Mancini N, Orsini A, Crucitti L, Forcina A, Lorentino F, Giglio F, Stanghellini MTL, Vago L, Morelli M, Girlanda S, Clerici D, Carrabba M, Marktel S, Assanelli A, Marcatti M, Bernardi M, Corti C, Peccatori J, Clementi M, Ciceri F, Barbanti, Mc, Greco, R, Mancini, N, Orsini, A, Crucitti, L, Forcina, A, Lorentino, F, Giglio, F, Stanghellini, Mtl, Vago, L, Morelli, M, Girlanda, S, Clerici, D, Carrabba, M, Marktel, S, Assanelli, A, Marcatti, M, Bernardi, M, Corti, C, Peccatori, J, Clementi, M, and Ciceri, F

Published
2015

45. Second Haploidentical Hematopoietic Stem Cell Transplantation with Treosulfan-based Conditioning Regimen for Acute Leukemia in Relapse

Author

Peccatori J, Crucitti L, Greco R, Stanghellini MTL, Vago L, Cieri N, Giglio F, Morelli M, Assanelli A, Marcatti M, Carrabba M, Marktel S, Perini T, Lorentino F, Girlanda S, Corti C, Bernardi M, Ciceri F, Peccatori, J, Crucitti, L, Greco, R, Stanghellini, Mtl, Vago, L, Cieri, N, Giglio, F, Morelli, M, Assanelli, A, Marcatti, M, Carrabba, M, Marktel, S, Perini, T, Lorentino, F, Girlanda, S, Corti, C, Bernardi, M, and Ciceri, F

Published
2015

46. Facing the Rising Tide of Multidrug Resistant Gram-Negative Pathogens in Allogeneic HSCT with Nanosphere's Verigene((R)) System

Author

Greco R, Barbanti MC, Mancini N, Infurnari L, Pasciuta R, Forcina A, Vago L, Giglio F, Messina C, Morelli M, Perini T, Girlanda S, Carrabba MG, Stanghellini MTL, Marktel S, Assanelli A, Bernardi M, Corti C, Peccatori J, Clementi M, Ciceri F, Greco, R, Barbanti, Mc, Mancini, N, Infurnari, L, Pasciuta, R, Forcina, A, Vago, L, Giglio, F, Messina, C, Morelli, M, Perini, T, Girlanda, S, Carrabba, Mg, Stanghellini, Mtl, Marktel, S, Assanelli, A, Bernardi, M, Corti, C, Peccatori, J, Clementi, M, and Ciceri, F

Published
2015

47. Post Transplant Cyclophosphamide (PTCy) and Sirolimus for Haploidentical PBSC HSCT: favorable Immune Reconstitution and Low Rates of GvHD in 40 Patients

Author

Cieri N, Greco R, Crucitti L, Morelli M, Giglio F, Levati G, Assanelli A, Lorentino F, Stanghellini MTL, Vago L, Freitas T, Marktel S, Bernardi M, Corti C, Bonini C, Ciceri F, Peccatori J, Cieri, N, Greco, R, Crucitti, L, Morelli, M, Giglio, F, Levati, G, Assanelli, A, Lorentino, F, Stanghellini, Mtl, Vago, L, Freitas, T, Marktel, S, Bernardi, M, Corti, C, Bonini, C, Ciceri, F, and Peccatori, J

Published
2015

48. Standardized care of long-term survivors after allogeneic stem cell transplantation: a cross-sectional 1-year evaluation in 249 adults

Author

Lupo-Stanghellini MT, Orsini A, Mastaglio S, Girlanda S, Perini T, Brambilla M, Tassara M, Lorentino F, Piemontese S, Forcina A, Vago L, Pavesi F, Sala E, Malerba A, Marcatti M, Guggiari E, Marktel S, Assanelli A, Carrabba M, Lunghi F, Bernardi M, Peccatori J, Corti C, Ciceri F, Lupo-Stanghellini, Mt, Orsini, A, Mastaglio, S, Girlanda, S, Perini, T, Brambilla, M, Tassara, M, Lorentino, F, Piemontese, S, Forcina, A, Vago, L, Pavesi, F, Sala, E, Malerba, A, Marcatti, M, Guggiari, E, Marktel, S, Assanelli, A, Carrabba, M, Lunghi, F, Bernardi, M, Peccatori, J, Corti, C, and Ciceri, F

Published
2015

50. Human Herpes Virus 6 Encephalitis: a major challenge after Haploidentical Hematopoietic Stem Cell Transplantation

Author

Greco R, Noviello M, Vago L, Stanghellini MTL, Cieri N, Oliveira G, Giglio F, Morelli M, Valtolina V, Barbanti MC, Lorentino F, Crucitti L, Orsini A, Forcina A, Assanelli A, Carrabba M, Marktel S, Bernardi M, Corti C, Peccatori J, Bordignon C, Bonini C, Ciceri F, Greco, R, Noviello, M, Vago, L, Stanghellini, Mtl, Cieri, N, Oliveira, G, Giglio, F, Morelli, M, Valtolina, V, Barbanti, Mc, Lorentino, F, Crucitti, L, Orsini, A, Forcina, A, Assanelli, A, Carrabba, M, Marktel, S, Bernardi, M, Corti, C, Peccatori, J, Bordignon, C, Bonini, C, and Ciceri, F

Published
2015

Catalog

Books, media, physical & digital resources
See catalog results